Unió Europea - anglès - EMA (European Medicines Agency)

fondazione telethon ets - autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ada) cdna sequence from human haematopoietic stem/progenitor (cd34+) cells - severe combined immunodeficiency - immunostimulants, - strimvelis is indicated for the treatment of patients with severe combined immunodeficiency due to adenosine deaminase deficiency (ada-scid), for whom no suitable human leukocyte antigen (hla)-matched related stem cell donor is available (see section 4.2 and section 4.4).

Israel - anglès - Ministry of Health

lapidot medical import and marketing ltd - metronidazole - solution for infusion - metronidazole 500 mg / 100 ml - metronidazole - metronidazole - treatment and prophylaxis of infection which are or may be due to anerobic bacteria,especially bacteriodes species,including bacteriodes fragilis, fusobacterium,eurobacterium and clostridium species.

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - busulfan - tablets - 0.5 milligram

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - miconazole - oral gel - 20mg/g mg/5ml - antiinfectives and antiseptics for local oral treatment

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

johnson & johnson (ireland) limited - miconazole - oral gel - 20 milligram(s)/gram - antiinfectives and antiseptics for local oral treatment; miconazole

Israel - anglès - Ministry of Health

raz pharmaceutics ltd, israel - melphalan as hydrochloride - powder and solvent for solution for injection/infusion - melphalan as hydrochloride 50 mg - melphalan - for the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial cancer of the ovary.

Unió Europea - anglès - EMA (European Medicines Agency)

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastic agents - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma.phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults.phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - melphalan - powder and solvent for solution for infusion - 50 milligram(s) - nitrogen mustard analogues; melphalan

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aspen medical products malaysia sdn bhd - busulphan -

Malàisia - anglès - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aspen medical products malaysia sdn bhd - melphalan -